Literature DB >> 33573391

Recruitment of Healthcare Providers into Research Studies.

Jill Bruneau1, Donna Moralejo1, Catherine Donovan2, Karen Parsons1.   

Abstract

Recruitment of a sufficient number of healthcare providers (HCPs), such as nurses and nurse practitioners (NPs), as participants is essential to generate high quality research to address issues significant for clinical practice. Often the recruitment process reported in research studies is very brief and does not capture the reality of the challenges of obtaining an adequate sample. This manuscript describes the challenges that we experienced in trying to recruit a sufficient number of HCPs, specifically NPs, into a randomized controlled trial. Based on our experience, as well as a review of the literature on recruiting HCPs, we share recommendations for researchers trying to recruit busy professionals as participants. Key findings were not just about reaching the target participants, but actually using strategies to stimulate their interest and persuading them to be involved from the beginning. Important things to consider for successful recruitment are making an effort to meet with professionals face-to-face and building relationships with administrators and other staff within organizations. Other lessons learned were to ensure to allot extra time for recruitment to allow for unanticipated challenges and to utilize multimodal strategies simultaneously to ensure a more timely execution of the recruitment process.

Entities:  

Keywords:  healthcare provider; nurse; nurse practitioner; recruitment; research

Year:  2021        PMID: 33573391     DOI: 10.1177/0844562120974911

Source DB:  PubMed          Journal:  Can J Nurs Res        ISSN: 0844-5621


  1 in total

1.  Characterizing experiences of non-medical switching to trastuzumab biosimilars using data from internet-based surveys with US-based oncologists and breast cancer patients.

Authors:  Elizabeth Lerner Papautsky; Martha Carlson; Sheila M Johnson; Hannah Montague; Deanna J Attai; Maryam B Lustberg
Journal:  Breast Cancer Res Treat       Date:  2022-05-14       Impact factor: 4.624

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.